The 1st skin care product with lasting action at the source of redness.
Long-lasting action directly targets the source of redness.
Co-developed with dermatologists.
ANTI-REDRESSING INNOVATION: acts at the source of redness
PATENTED INNOVATIVE ACTIVE: Angiopausine™ 6% for red skin
DEVELOPED WITH DERMATOLOGISTS
Usable by
Adults
Skin type
Normal skin - Sensitive skin - Sensitive skin prone to rashes - Reactive - intolerant skin
Need
Anti-redness due to dryness
Made in France
Co-developed with dermatologists, REDNESS EXPERT skin care reduces the appearance of established redness, and its anti-recurrence action helps limit its reappearance. It immediately soothes sensations of overheating and moisturizes for 24H* to restore skin comfort.
The result of over 3 years' research, our active ingredient Angiopausine™ , derived from milk thistle, at 6%, reduces superficial hypervascularization. Active ingredient 100% natural origin.
Light, non-greasy cream. Fragrance-free for sensitive and reactive skin. Excellent make-up base.
Biodegradable formula*
Formulated to limit the impact on the aquatic environment***
98% natural origin formula
*According to an OECD 301 test or a biodegradability index
*** According to an OECD 301 test and CLP classification of the formula
Packaging
Fully recyclable packaging
Manufacturing
Manufactured and packaged in an environmentally certified facility****
****According to ISO 14001 and/or 50001
Transportation
Low CO2 impact of raw material transport (< 70 g CO2 eq. )
Societal impact
Product manufactured and packaged in a factory with high social compliance
Avène is a brand of the Pierre Fabre Group, certified at the highest Exemplary level of AFNOR Certification’s ‘Committed to CSR’ and ‘Responsibility Europe’ labels, thus consolidating a long-standing commitment to sustainable development.
Does ... not contain raw materials of animal origin
Our commitments
The consumer is advised to systematically check the composition of the product before purchasing it.
Angiopausine™
6% - Anti-redness active ingredient with patented properties*. Reduces hypervascularization.
*Patent pending.
Results
Clinically proven effectiveness:
-48% reduction in redness intensity¹
Anti-recurrence²
¹Clinical study. Evaluation according to GFSS (Global Flushing Severity Score), 41 subjects, 2 applications per day for 29 days.
²Use 2 times a day for 1 month. Redness reappearance limited for 2 weeks after treatment discontinuation.
Alii autem, quibus ego assentior, cum soluta nobis est eligendi optio, cumque nihil ut et via procedat oratio quaerimus igitur, inquit, sic agam, ut alterum esse appetendum, alterum esse fugiendum itaque earum rerum hic tenetur a sapiente delectus, ut.
